Tablet

Teneligliptin 20mg

Teneligliptin Hydrobromide Hydrate

Novel DPP-4 inhibitor with a unique thiazolidine-based structure providing prolonged enzyme inhibition, approved in India, Japan, and South Korea for type 2 diabetes management. A more affordable alternative to patent-protected DPP-4 inhibitors, it has gained significant market share in Asia and emerging markets with an established safety profile.

Strengths

20mg / 40mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request Quotation WhatsApp

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition

Teneligliptin Hydrobromide Hydrate equivalent to Teneligliptin 20mg / 40mg

Dosage Form

Tablet

Available Strengths

20mg / 40mg

Packing

10 tablets/strip

Route of Administration

Oral, with or without food

Dosage

20mg once daily; may increase to 40mg once daily if response is inadequate

Indications

Type 2 diabetes mellitus (monotherapy or combination with metformin, glimepiride, pioglitazone, or insulin)

Country of Origin

India (WHO-GMP Certified)

Storage

Store at 25°C, protected from moisture

Shelf Life

36 months

Side Effects

Nasopharyngitis, hypoglycemia (when combined with sulfonylurea or insulin), constipation, headache, QT prolongation (rare at higher doses)

Precautions

Caution in cardiac arrhythmias (QT interval); dose adjustment in moderate-severe renal impairment; monitor blood glucose; pancreatitis risk (class effect)

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Tablet

Glimepiride 2mg

Glimepiride

Third-generation sulfonylurea that stimulates pancreatic beta-cell insulin secretion via selective SUR1 receptor binding, offering a lower hypoglycemia risk compared to earlier sulfonylureas due to glucose-dependent activity. The most cost-effective oral antidiabetic agent in its class and a cornerstone of type 2 diabetes management in emerging markets.

1mg / 2mg / 3mg / 4mg

Tablet

Sitagliptin 100mg

Sitagliptin Phosphate

First-in-class DPP-4 inhibitor that amplifies incretin-mediated glucose-dependent insulin secretion while suppressing glucagon, offering glycemic control without weight gain or intrinsic hypoglycemia risk. Once-daily dosing, renal dose adjustment flexibility, and a decade-long cardiovascular safety record make it a globally preferred add-on antidiabetic.

25mg / 50mg / 100mg

Tablet

Vildagliptin 50mg

Vildagliptin

Selective DPP-4 inhibitor with potent enzyme inhibition that improves glycemic control through enhanced incretin-mediated insulin secretion and suppressed post-meal glucagon release. Widely prescribed as a fixed-dose combination with metformin (Galvusmet) offering convenient dual-mechanism therapy without weight gain.

50mg

Need bulk pricing for Teneligliptin 20mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote